Cargando…

Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors

Transporters belonging to the Resistance-Nodulation-cell Division (RND) superfamily of proteins such as Mycobacterium tuberculosis MmpL3 and its analogs are the focus of intense investigations due to their importance in the physiology of Corynebacterium–Mycobacterium–Nocardia species and antimycobac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevens, Casey M., Babii, Svitlana O., Pandya, Amitkumar N., Li, Wei, Li, Yupeng, Mehla, Jitender, Scott, Robyn, Hegde, Pooja, Prathipati, Pavan K., Acharya, Atanu, Liu, Jinchan, Gumbart, James C., North, Jeffrey, Jackson, Mary, Zgurskaya, Helen I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335285/ https://www.ncbi.nlm.nih.gov/pubmed/35858440 http://dx.doi.org/10.1073/pnas.2113963119

Ejemplares similares

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
por: Li, Wei, et al.
Publicado: (2019)

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
por: Li, Wei, et al.
Publicado: (2018)

Cryo-EM structure of the trehalose monomycolate transporter, MmpL3, reconstituted into peptidiscs
por: Couston, Julie, et al.
Publicado: (2023)

Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
por: McNeil, Matthew B., et al.
Publicado: (2020)

Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosis
por: Li, Ming, et al.
Publicado: (2020)

Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
por: Li, Wei, et al.
Publicado: (2017)

Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis
por: Yamamoto, Kentaro, et al.
Publicado: (2021)

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020)

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
por: Sethiya, Jigar P., et al.
Publicado: (2020)

Study of SQ109 analogs binding to mycobacterium MmpL3 transporter using MD simulations and alchemical relative binding free energy calculations
por: Stampolaki, Marianna, et al.
Publicado: (2023)

MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
por: Melly, Geoff, et al.
Publicado: (2019)

Molecular Mechanisms of MmpL3 Function and Inhibition
por: Williams, John T., et al.
Publicado: (2023)

The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria
por: Belardinelli, Juan Manuel, et al.
Publicado: (2019)

Targeting MmpL3 for anti-tuberculosis drug development
por: Bolla, Jani R.
Publicado: (2020)

MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
por: Varela, Cristian, et al.
Publicado: (2012)

Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
por: Strong, Emily J., et al.
Publicado: (2018)

Structure-function analysis of MmpL7-mediated lipid transport in mycobacteria
por: Moolla, Nabiela, et al.
Publicado: (2021)

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
por: Fay, Allison, et al.
Publicado: (2019)

Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
por: Degiacomi, Giulia, et al.
Publicado: (2017)

The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation
por: Parish, Tanya
Publicado: (2022)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport
por: Su, Chih-Chia, et al.
Publicado: (2021)

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
por: Hanieh, Patrizia Nadia, et al.
Publicado: (2022)

Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10
por: Ahmed, Mohamed, et al.
Publicado: (2022)

Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
por: Shetty, Annanya, et al.
Publicado: (2018)

Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target
por: Adams, Oliver, et al.
Publicado: (2021)

Phospholipid homeostasis, membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11 function
por: Bothra, Ankur, et al.
Publicado: (2018)

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
por: Ray, Peter C., et al.
Publicado: (2021)

A Hydrazine–Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3
por: Briffotaux, Julien, et al.
Publicado: (2022)

MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines
por: Maslov, Dmitry A., et al.
Publicado: (2020)

Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
por: Poce, Giovanna, et al.
Publicado: (2013)

Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans
por: Ishwarlall, Tamara Z., et al.
Publicado: (2023)

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
por: Shahbaaz, Mohd, et al.
Publicado: (2022)

Two putative MmpL homologs contribute to antimicrobial resistance and nephropathy of enterohemorrhagic E. coli O157:H7
por: Hussein, Salma H., et al.
Publicado: (2019)

Membrane thinning and lateral gating are consistent features of BamA across multiple species
por: Liu, Jinchan, et al.
Publicado: (2020)

Inhibition Mechanism of Anti-TB Drug SQ109: Allosteric Inhibition of TMM Translocation of Mycobacterium Tuberculosis MmpL3 Transporter
por: Carbone, Justin, et al.
Publicado: (2023)

In vivo imaging of MmpL transporters reveals distinct subcellular locations for export of mycolic acids and non-essential trehalose polyphleates in the mycobacterial outer membrane
por: Thouvenel, Laurie, et al.
Publicado: (2023)

The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation
por: Moorey, Alice R., et al.
Publicado: (2021)

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
por: Imran, Mohd., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qrat1imdlbi2achue95eh19ne